Editors: Kamal Niaz, Muhammad Farrukh Nisar

Series Title: Coronavirus Disease-19 (COVID-19): A Perspective of New Scenario

COVID-19: Epidemiology, Biochemistry, and Diagnostics

Volume 1

eBook: US $79 Special Offer (PDF + Printed Copy): US $142
Printed Copy: US $103
Library License: US $316
ISBN: 978-981-4998-94-9 (Print)
ISBN: 978-981-4998-93-2 (Online)
Year of Publication: 2021
DOI: 10.2174/97898149989321210101


COVID-19: Epidemiology, Biochemistry, and Diagnostics explains COVID-19 from multidisciplinary angles such as the evolution of SARS-COV, genetic techniques to study the virus, and diagnostic methodologies widely used in the global COVID-19 pandemic.

The chapters in this book provide the reader with up-to-date literature about research on SARS-CoV-2 through three parts:

I) Evolution and Entry of SARS-CoV-2 into the host

II) Genetic Alteration and Structural Determination of SARS-CoV-2 Proteins

III) Quantitative Analysis of SARS-CoV-2 for research and medical diagnosis

Key Features:

- 15 chapters on SAR-CoV-2 in a multidisciplinary context

- Provides a comprehensive overview of SARS-CoV-2 evolution and genetics

- Provides biochemical information about SARS-CoV-2 proteins and receptor targets (both structural and non-structural proteins)

- Includes an overview of several methods of detecting SARS-CoV-2 virus particles (ELISA, PCR, Neutralizing Antibodies

- Covers some critical diagnostic modalities for COVID-19 diagnosis

- Provides bibliographic references for further reading

Readers will understand the significance of phylogenetic analysis of coronaviruses, along with the pathogenesis of COVID-19 and related diseases such as SARS and MERS. Applications of biochemical technologies such as RT-PCR and CRISPR are also demonstrated in the text. This book is a comprehensive introduction to COVID-19 research for medical researchers, microbiologists and virologists. Students in academic programs in life sciences and medicine will also benefit from the information provided in the book.


The connection between human health, animals, and the environment has been widely recognized as important for the ecosystem we inherit and intend to improve for the generations to come. This of course is not a responsibility of a region or a country, rather its responsibility of all of us. Efforts have to be collaborative and transboundary in approach. Of the many types of challenges, respiratory diseases have emerged as a real threat in the recent past. Scientists have been working to reduce their load and easily spread it from animals to human beings. Newly emerging respiratory diseases such as severe acute respiratory syndrome-coronavirus (SARS-CoV), Middle East respiratory syndrome (MERS), and severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) posing a serious threat to the human population and reported in the year 2003, 2012, and 2019, respectively.

This book is very relevant in this connection. The volume-1 of this book consists of three key modules. The first module provides clearly defined progression and entry of SARS-CoV-2 to the human population. The learning outcomes of this module are developing knowledge, skills, and competencies in scientists, students, employers, and human resource specialists. The other modules of this book focus on developing a detailed set of guidelines regarding epidemiology, genetic alteration, a structural protein, quantitative analysis, and diagnostic approaches of SARS-CoV-2 and will give step-by-step awareness to the researchers about SARS-CoV-2. This book will be adopted to give reliable knowledge to all scientists globally. I hope that this book will be distributed widely in Pakistani higher institutions in the near future for thorough implementation at all levels of postgraduate studies.

Muhammad Sajjad Khan
Cholistan University of Veterinary and Animal Sciences


.Emerging Approaches to Tackle Neglected Diseases: From Molecule to End Product.
.COVID 19 – Monitoring with IoT Devices.
.Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents.
.Recent Trends and The Future of Antimicrobial Agents - Part 2.